论文部分内容阅读
肺癌为世界上最常见恶性肿瘤之一,已位居我国城市人口恶性肿瘤死亡原因首位,其中非小细胞肺癌(NSCLC)占肺癌80%,患者主要因吸烟、职业与环境接触、电离辐射、既往肺部慢性感染、遗传及大气污染等因素而起病~([1])。随综合治疗方案不断发展,NSCLC患者5年生存率有所提高,但仍徘徊在15%左右,临床对其手术方法存在较大争议,电视胸腔镜(VATS)应用于肺癌的治疗已达20年之久,随器械与技术日益改进,其在全国各地迅速发展,相较于传统手术,VAST微创术具有术
Lung cancer is one of the most common malignancies in the world, and it ranks first among the causes of death from malignant tumors in the urban population in China. Among them, non-small cell lung cancer (NSCLC) accounts for 80% of lung cancers. Patients mainly suffer from smoking, occupational and environmental exposure, and ionizing radiation. Chronic lung infections, heredity and atmospheric pollution and other factors onset ~ ([1]). With the continuous development of comprehensive treatment programs, the 5-year survival rate of patients with NSCLC has increased, but it is still hovering around 15%. There is a controversy about its clinical surgical methods. The application of video-assisted thoracoscope (VATS) to lung cancer has reached 20 years. For a long time, with the improvement of equipment and technology, it has developed rapidly throughout the country. Compared with traditional surgery, VAST minimally invasive surgery has